Lobbying Governance
| Overall Assessment | Analysis | Score |
|---|---|---|
| Strong |
Tianjin Pharmaceutical Da Re Tang Group describes a clear internal mechanism to keep lobbying and other external engagements consistent with its climate objectives. It states that "DRT has quarterly meetings with all departments … during which all sustainability aspects, including climate change, are reviewed … including those around activities that influence climate-related policy, and ensure consistency with DRT’s climate change and CSR strategy," showing a recurring forum where such alignment is checked. Oversight is assigned to a specific senior individual: "Our Director of CSR and Institutional Relations is primarily responsible for DRT’s overall climate change and CSR strategy" and this Director "determines whether the activities are properly aligned … If activities are aligned, activities will be approved and documented … For activities that do not align with our strategy, the Director … declines to participate." The Director’s remit explicitly covers both direct and indirect advocacy, as they "gain a deep understanding of any potential direct or indirect activities that DRT may pursue" and also "sit on the board of these organizations, thus ensuring that their policies are consistent with DRT’s," indicating that the company can influence, correct, or withdraw from external associations whose climate positions diverge from its own. This combination of a standing review process, documented approval/decline decisions, and a named responsible officer demonstrates strong governance of both direct and indirect climate-related lobbying; however, the company does not disclose board-level oversight or a published lobbying-alignment audit, so transparency and accountability could be enhanced.
View Sources
|
B |